Lower open on retreating crude oil prices

Retreating crude oil prices weighed the markets down to a lower open with the Dow falling 54 points to 17,983. Nasdaq lost 17 points to 4,789.

On the upside

NeuroDerm (Nasdaq: NDRM) reported positive results from a Phase IIa study of ND0612H and ND0612L in treating Parkinson's Disease.

Corvex Management acquired a 7.1% stake in American Realty Capital Properties (Nasdaq: ARCP).

Rising gold prices lifted shares of Barrick Gold (NYSE: ABX), Kinross Gold (NYSE: KGC) and Yamana Gold (NYSE: AUY).

On the downside

Civeo (NYSE: CVEO) suspended its dividend and forecast 2015 earnings and revenue that fell far short of analyst expectations.

Atossa Genetics (Nasdaq: ATOS) extended its losses.

Investors locked in profits on LiveDeal (Nasdaq: LIVE).

In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by nearly 5 to 3 on Nasdaq. The broader S&P 500 lost 7 points to 2083. Bitcoin eased $1 to $310.